Basic Information
Myxobio is the world's only myxobacterial platform company, utilizing myxobacteria as a unique resource to develop a series of biomanufacturing projects. To date, the company has established five major product pipelines: green agriculture, health foods, life health, biomedicine, and research services. Myxobacteria are prokaryotic organisms that hold a distinctive and crucial position in the microbial world. Their remarkable characteristics demonstrate significant application potential in fields such as green agriculture and biomedicine. The company’s current products include fungal cell wall lytic enzymes, among which the fungal cell wall lytic enzyme is China's first fully functional, broad-spectrum, and highly efficient enzyme of its kind, derived from δ-proteobacteria, providing robust support for fungal protoplast preparation. Adhering to the values of "progress, innovation, cooperation, and win-win," Myxobio integrates attributes of scarcity, uniqueness, innovation, and scalability, committing itself to creating a green, safe, and comfortable world through microbiology.